Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

733 ARTÍCULOS , VIENDO DEL 541 AL 555

Use of anti-amyloid-β monoclonal antibodies in persons with Down syndrome Alzheimer's disease

Farrell C, Saini F, Beidas MM, Ryan NS, Strydom A, Wiseman FK.

Alzheimers Dement. 2026 Apr;22(4):e71404. doi: 10.1002/alz.71404.

A phase 2, randomized, multicenter, double-blind, placebo-controlled trial of S-adenosyl methionine in participants with mild cognitive impairment or dementia due to Alzheimer's disease

Holper S, Barnham KJ, Churilov L, Yates P, Brodtmann A, Johns S, Li QX, Bhalala O, Chin KS, Loveland P, Yu JJ, Masters CL, Watson R, Yassi N.

Alzheimers Dement. 2026 Apr;22(4):e71381. doi: 10.1002/alz.71381.

Therapeutic Options for Alzheimer's Disease and Aging-Associated Cognitive Decline: State of the Art in the ACH2.0 Paradigm

Volloch V, Rits-Volloch S.

Int J Mol Sci. 2026 Feb 2;27(3):1486. doi: 10.3390/ijms27031486.

Application of Photostimulation Therapy in Cognitive Function of Alzheimer's Disease Patients: A Scoping Review

Xu B, Wan H, Liu P, Zhao Z, Xie Y, Meng J, Qin Y.

Clin Interv Aging. 2026 Apr 24;21:600468. doi: 10.2147/CIA.S600468. eCollection 2026.

Elucidating the phase 1 trial experience among study participants following completion of the INTERCEPT-AD study of sabirnetug (ACU193) for early Alzheimer's disease: a qualitative interview study

Merikle E, Presnall C, Feaster T, Moxon R, Siemers E, Kerwin D, Cline S.

Trials. 2026 Mar 23;27(1):339. doi: 10.1186/s13063-026-09656-w.

From brain waves to heartbeats: Exploring the combined role of electroencephalography and heart-rate variability in Alzheimer's disease diagnosis and management

Botchway BOA, Kousiappa I, Koupparis A, Papacostas S, Georgiades S, Bashiardes S, Hadjisavvas A, Loucaides G, Adamou A, Christou Y, Panayiotidis MI, Jovanovic A, Nicolaou N.

J Alzheimers Dis. 2026 May;111(1):5-31. doi: 10.1177/13872877261428636. Epub 2026 Mar 13.

Validation of a novel cognitive-functional outcome measure optimized for early Alzheimer's Disease: Evidence from the VIVA-MIND trial

Duehring JA, Jacobs DM, Salmon DP, MacKelfresh AJ, Revta C, Meyer A, Schaeffer M, Schell-Mader S, Wassmann T, Wenzkowski C, Feldman HH, Edland SD; ADCS VIVA-MIND Study Group.

J Prev Alzheimers Dis. 2026 May;13(5):100531. doi: 10.1016/j.tjpad.2026.100531. Epub 2026 Mar 13.

Comparing Functional Consequences of Human iPSC-Microglia and Neural Stem Cell-Derived Extracellular Vesicles in Mitigating Cognitive Decline in Alzheimer's Disease

Krattli RP Jr, Markarian M, Madan S, Swami D, McQuade A, Baulch JE, Blurton-Jones M, Acharya MM.

Aging Cell. 2026 Jan;25(1):e70341. doi: 10.1111/acel.70341.

Evidence integration of acupuncture for prevention and treatment of Alzheimer's disease and mild cognitive impairment from a neuroimaging perspective

Zhu W, Li H, Wang K, Sun M, Xiang K, Shan S, Ke C.

J Alzheimers Dis. 2026 Apr;110(3):1038-1056. doi: 10.1177/13872877261420235. Epub 2026 Mar 20.

Longitudinal Multi-Domain Cognitive Assessment of Anti-Amyloid Monoclonal Antibodies Versus Acetylcholinesterase Inhibitors in Early Alzheimer's Disease: A Systematic Review and Meta-Analysis

Lee CY, Hsu TW, Kao YC, Tseng PT, Hsu CW, Lin YH, Liang CS.

Geriatr Gerontol Int. 2026 Apr;26(4):e70492. doi: 10.1111/ggi.70492.

Treatment of Clinically Diagnosed Alzheimer's Disease by External Counterpulsation A Randomized Clinical Trial

Juni JE, Burns JM, Salat DH, Hill D, Tally S, Martin JS, Devous MD, Moriarty PM.

Am J Alzheimers Dis Other Demen. 2026 Jan-Dec;41:15333175261451918. doi: 10.1177/15333175261451918. Epub 2026 May 14.

Characteristics of infusion-related reactions to lecanemab in early Alzheimer's disease: A multicenter real-world study in Northwestern China

Liu P, Liu J, Wang J, Du Y, Liu Z, Zhang H, Zhu A, Zhang G, Meng X, Zhao C, Zhang W, Dang L, Zhang W, Qu Q, Qu Y.

J Prev Alzheimers Dis. 2026 May;13(5):100542. doi: 10.1016/j.tjpad.2026.100542. Epub 2026 Mar 19.

Pharmacotherapeutic landscape for the management of agitation associated with Alzheimer's disease

Jain S, Tunc EB, Grossberg GT.

Expert Opin Pharmacother. 2026 Apr;27(6):531-544. doi: 10.1080/14656566.2026.2662949. Epub 2026 Apr 21.

Angiogenic and anti-angiogenic factors are the shared mechanistic pathways between preeclampsia and Alzheimer's disease: Perspective and take-away

Abbas AM, Al-Kuraishy HM, Al-Maiahy TJ, Al-Gareeb AI, Alharbi W, Fawzy MN, Batiha GE.

Vascul Pharmacol. 2026 Mar;162:107583. doi: 10.1016/j.vph.2026.107583. Epub 2026 Feb 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias